These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16239211)

  • 1. Idle thoughts from an addled mind. All roads lead to...
    Service FJ
    Endocr Pract; 2005; 11(3):208. PubMed ID: 16239211
    [No Abstract]   [Full Text] [Related]  

  • 2. Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force.
    Jellinger PS; Davidson JA; Blonde L; Einhorn D; Grunberger G; Handelsman Y; Hellman R; Lebovitz H; Levy P; Roberts VL;
    Endocr Pract; 2007; 13(3):260-8. PubMed ID: 17599857
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines ease up on glycemic control for some patients with type 2 diabetes.
    Mitka M
    JAMA; 2012 Jun; 307(21):2243-4. PubMed ID: 22706812
    [No Abstract]   [Full Text] [Related]  

  • 4. [Exenatide convinces in a six-month study: HbA1c sunk significantly].
    MMW Fortschr Med; 2009 May; 151(19):51. PubMed ID: 19827448
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rapaglinide: Novonorm, an alternative in type 2 diabetes].
    Bouhanick B; Barbosa SS
    Presse Med; 2000 May 27-Jun 3; 29(19):1059-61. PubMed ID: 10874917
    [No Abstract]   [Full Text] [Related]  

  • 6. HbA1c in the Evaluation of Diabetes Mellitus.
    O'Keeffe DT; Maraka S; Rizza RA
    JAMA; 2016 Feb; 315(6):605-6. PubMed ID: 26864415
    [No Abstract]   [Full Text] [Related]  

  • 7. The target for good glycemic control should be an Hb A(1C) concentration of less than 0.07.
    Matz R
    West J Med; 2000 Sep; 173(3):179-80. PubMed ID: 10986180
    [No Abstract]   [Full Text] [Related]  

  • 8. Acarbose: in search for its real indications in current medical practice.
    Lerman I; Gómez Perez FJ; Aguilar-Salinas CA; Rodrigo JA
    Diabetes Care; 1996 Jan; 19(1):94-5. PubMed ID: 8720547
    [No Abstract]   [Full Text] [Related]  

  • 9. Revised standards for the treatment of type 2 diabetes in Texas.
    Davidson J
    Diabetes Care; 1999 Jul; 22(7):1219-20. PubMed ID: 10388996
    [No Abstract]   [Full Text] [Related]  

  • 10. The EASD/ADA consensus: trick or treat?
    Grant PJ
    Diab Vasc Dis Res; 2009 Jan; 6(1):5-6. PubMed ID: 19156621
    [No Abstract]   [Full Text] [Related]  

  • 11. HbA1C, finding the right target in 2018.
    Vela D
    Diabetes Metab Syndr; 2018 Jul; 12(4):607-608. PubMed ID: 29622471
    [No Abstract]   [Full Text] [Related]  

  • 12. [Initial therapy of diabetes mellitus in the family practice. Give yourself time!].
    MMW Fortschr Med; 2008 Oct; 150(42):25. PubMed ID: 18985907
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical decisions. Management of type 2 diabetes--polling results.
    Schulte JM; Rothaus CS; Adler JN
    N Engl J Med; 2014 Jan; 370(1):e2. PubMed ID: 24382086
    [No Abstract]   [Full Text] [Related]  

  • 14. Comments on the AACE/ACE statement on glycemic control for patients with type 2 diabetes mellitus.
    Eledrisi M
    Endocr Pract; 2010; 16(1):130-1; author reply 131-2. PubMed ID: 20146995
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral antidiabetic drug therapy in type 2 diabetes mellitus - focus on elderly patients.
    Lechleitner M
    Wien Med Wochenschr; 2011 Jun; 161(11-12):297-9. PubMed ID: 21769711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of exercise training on doses of oral agents and insulin.
    Fujinuma H; Abe R; Yamazaki T; Seino H; Kikuchi H; Hoshino T; Hirano R; Yoshida S
    Diabetes Care; 1999 Oct; 22(10):1754-5. PubMed ID: 10526756
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycemic durability of monotherapy for diabetes.
    Rathmann W; Kostev K; Haastert B
    N Engl J Med; 2007 Mar; 356(13):1378-9; author reply 1380. PubMed ID: 17392313
    [No Abstract]   [Full Text] [Related]  

  • 18. [New therapeutic approaches in type 2 diabetes mellitus].
    Zafon C
    Med Clin (Barc); 2015 Dec; 145(11):485-7. PubMed ID: 26142571
    [No Abstract]   [Full Text] [Related]  

  • 19. Type 2 diabetes: which glucose-lowering drug, if any, after metformin?
    Prescrire Int; 2015 May; 24(160):135. PubMed ID: 26034807
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study finds more fatalities than in lax blood glucose control. Is HbA(1c) of 6.5% too low for the type 2 diabetes patient? (interview by Maria Weiss)].
    Haak T
    MMW Fortschr Med; 2008 Mar; 150(10):17. PubMed ID: 18447283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.